A measure of growth - but companies need to be more forthcoming with market and sales data
This article was originally published in Clinica
Devices and diagnostics are growth markets; that much is sure. The top 20 companies show impressive high single-digit or mid- high-teens sales growth year-on-year...take for example at 2003 year-end Becton Dickinson +12% to $4.5bn, Fresenius +9% to $4.1bn and J&J +18.5% to $14.9bn. And after nine months GEMS +11%, Guidant +20%, Stryker +20%, Baxter +9%, Boston +21%, Zimmer +20%, etc....They measure up well in terms of sales performance quarter by quarter, and it's easy to track where the gains are being made.